.
Labcorp to buy some CHS assets for $195M

Labcorp to buy some CHS assets for $195M

The deal includes outreach laboratory services in 13 states. CHS will continue to operate its inpatient and emergency department labs...

Aidoc raises $150M for AI foundation model

Aidoc raises $150M for AI foundation model

The technology, called CARE, is expected to allow for faster development of AI models that can cover more health conditions....

10M people will lose insurance due to GOP policy law

10M people will lose insurance due to GOP policy law

The final tally from the nonpartisan budget scorekeeper estimates the law will decrease federal healthcare spending by $1.1 trillion over...

Judge dismisses Humana’s Medicare Advantage star ratings suit

Judge dismisses Humana’s Medicare Advantage star ratings suit

Analysts estimate Humana could lose billions of dollars as a result of the decision. Article By: Rebecca Pifer Blog Source...

CMS proposes covering renal denervation for hypertension

CMS proposes covering renal denervation for hypertension

Medtronic and Recor Medical stand to benefit from national Medicare coverage for their new device-based treatments for patients with uncontrolled...

The Trump administration wants to onshore drug manufacturing. Technologists are answering the call.

The Trump administration wants to onshore drug manufacturing. Technologists are answering the call.

Looming threats to the pharmaceutical supply chain have brought fresh attention to onshoring. Experts say innovation is happening, but slowly. Article...

Optum Rx slashes reauthorization requirements for more drugs

Optum Rx slashes reauthorization requirements for more drugs

The UnitedHealth-owned pharmacy benefit manager has removed reauthorization requirements for more than 140 drugs so far this year. Article By: Susanna...

FDA stops Olympus devices from entering the US

FDA stops Olympus devices from entering the US

The agency said it issued the import alerts because it “continues to have concerns related to outstanding Quality System regulation...

CVS Caremark to pay $95M in Medicare fraud case

CVS Caremark to pay $95M in Medicare fraud case

A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for generic drugs....